Articles Tagged With:
-
FDA’s Change to Emergency Contraception Labeling Is Good News for Women
In a move that expands access to contraception, the FDA announced that it was changing packaging labels for Plan B, the emergency contraceptive pill that is available over the counter. The box no longer will carry the baseless claim that the pill may prevent a fertilized egg from implanting in the womb.
-
Social Media Trends Are Moving Against Contraception Access
Reproductive health advocates and providers should be aware of a disturbing social media trend that appears to be moving in the same direction as the early anti-Roe efforts in the 1980s. Decades of attacks on abortion changed enough people’s opinions on abortion to lay the groundwork for the Supreme Court’s Dobbs v. Jackson Women’s Health Organization decision.
-
Fully Funded Access to Contraception Can Change an Entire Population’s Lives
The results of Colorado’s contraception expansion experiment are in, showing a dramatic improvement in women’s lives during the period in which Title X programs were fully funded through a grant. The Colorado Family Planning Initiative profoundly affected adolescent girls and young adults, resulting in a 6% to 12% increase in women obtaining their college degrees compared to earlier cohorts that did not benefit from the expanded contraception program, according to study results.
-
Probiotics and Iron Intake in Pregnancy
In a randomized controlled trial, a significantly smaller decrease in serum ferritin was observed in pregnant women with the intake of a Lactiplantibacillus plantarum 299v supplement containing a low dose of iron, folic acid, and ascorbic acid than in the placebo group.
-
Provider Perceptions of Neonatal Survival for Fetuses Born at 22 Weeks of Gestation
Prognostic differences exist among neonatal and obstetric care providers when neonates are delivered at 22 weeks of gestation. However, there are no statistically significant differences in the gestational age at which providers recommend active treatment or antenatal corticosteroids.
-
New Treatments for Uterine Fibroids
In this prospective, open-label, single-arm trial of 149 individuals with heavy menstrual bleeding and uterine leiomyomas, daily relugolix combination therapy (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg) resulted in a mean menstrual blood loss reduction of 90%, and 70% of the participants achieved amenorrhea by the end of the 52-week period. Similar results were found for other arms of the trial among women who crossed over from placebo and relugolix-only therapy to relugolix combination therapy.
-
#IUD on TikTok: An Analysis of Intrauterine Device-Related Content on Social Media
The top 100 videos on the social media platform TikTok were compiled and systematically analyzed for user demographics and video content. More videos had a negative tone, particularly those conveying patient experiences related to pain and informed consent.
-
Clinicians Are Ethically Obligated to Consider Financial Side of Care
Clinicians should include the cost of care in discussions, help patients access charity care or financial counseling, and screen patients for social determinants of health.
-
Effectively Intervening with Patients Facing Housing Instability
The notion that housing is healthcare stems from a growing body of research that links housing instability with higher rates of morbidity and mortality. There is a moral and humanitarian case for healthcare organizations to engage on the housing issue, but there also is a business case. But precisely how healthcare organizations should go about this work is not yet well established. Thus, IHI has partnered with Community Solutions, a nonprofit organization that is working to end homelessness, to examine how healthcare can play an effective role in addressing the problem.
-
Better Care Communication Needed for Home Health
Researchers wanted to know if there is an association between home health and gaps in care coordination among providers. They found patients receiving home healthcare are sicker, experienced more functional dependencies, and reported more preventable drug-drug interactions. While home health was not associated with a difference in gaps of care coordination, it was associated with twice the risk of a preventable adverse outcome.